Moderna Therapeutics' Corporate Minority - II Round

Moderna Therapeutics raised a round of funding on August 10, 2016. Investors include AstraZeneca.

Moderna Therapeutics is pioneering messenger RNA Therapeutics, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracell…

Articles about Moderna Therapeutics' Corporate Minority - II Round: